Skip to main content


14 Jun | 2021

The United States approves the commercialization of a drug that could slow down Alzheimer's disease

The last drug approved by the FDA was in 2003, and until now any treatment has proved to slow down the progression of the disease.

Read more
07 May | 2021

Dra. Eider Arenaza-Urquijo has been elected Vice President of an ISTAART Area of professional interest

The researcher of the Clinical Research Group, Biomarkers and Risk Factors of the BBRC will vice-chair the group "Reserve, Resilience and Protective Factors of the International Society to advance research and treatment of Alzheimer’s

Read more

Latest Tweets


Customized integral service for research projects with cerebral magnetic resonance imaging